Home Articles List Article Information
Journal of Pharmaceutical & Health Sciences
Journal Archive
Volume Volume 6 (2018)
Volume Volume 5 (2017)
Volume Volume 4 (2016)
Volume Volume 3 (2015)
Volume Volume 2 (2013-2014)
Volume Volume 1 (2012-2013)
Avadi, M., Nadjari, A., Naeimi, M. (2018). Preparation and release study of Levetiracetam 500 mg extended release tablet by using combination of hydrophilic and hydrophobic polymers.. Journal of Pharmaceutical & Health Sciences, 6(2), 157-168.
Mohamad Reza Avadi; Aida Nadjari; Masoumeh Sadat Naeimi. "Preparation and release study of Levetiracetam 500 mg extended release tablet by using combination of hydrophilic and hydrophobic polymers.". Journal of Pharmaceutical & Health Sciences, 6, 2, 2018, 157-168.
Avadi, M., Nadjari, A., Naeimi, M. (2018). 'Preparation and release study of Levetiracetam 500 mg extended release tablet by using combination of hydrophilic and hydrophobic polymers.', Journal of Pharmaceutical & Health Sciences, 6(2), pp. 157-168.
Avadi, M., Nadjari, A., Naeimi, M. Preparation and release study of Levetiracetam 500 mg extended release tablet by using combination of hydrophilic and hydrophobic polymers.. Journal of Pharmaceutical & Health Sciences, 2018; 6(2): 157-168.

Preparation and release study of Levetiracetam 500 mg extended release tablet by using combination of hydrophilic and hydrophobic polymers.

Article 7, Volume 6, Issue 2, Summer 2018, Page 157-168  XML PDF (469.94 K)
Document Type: Original Article
Authors
Mohamad Reza Avadi email 1; Aida Nadjari2; Masoumeh Sadat Naeimi3
1R&D manager of Hakim Pharmaceutical company
2pharmaceutical and physicochemical labratory,pharmacy faculty,islamic azad university of pharmaceutical sience,tehran,iran
3Hakim Pharmaceutical Company, Tehran, Iran (R&D Expert)
Abstract
Abstract
Levetiracetam as an Anti-epileptic drug with exclusive mechanism of action is accepted by the USA Food and Drug Administration as an adjunctive therapy in treating epilepsy in young adults.

The purpose of this project is the design and formulation of prolonged release of levetiracetam using two types of retarding agent such as Hydroxyl Propyl Methylcellulose (HPMC K4M) and xanthan Gum, as well as a fatty matrix of cetyl alcohol. In addition, by manufacturing this product, it is possible to make a domestic production of this form of medicine, importing this form of medicine into the list of generic drugs of Iran.

Pre-formulation studies such as compaction of granules, compressibility and the ability of powder to flow were observed prior to formulation. The percentage of excipients in the formulation such as HPMC K4M, PVP k30, Mg-st, were considered as variables to examine rate of release and physical properties in Factorial design method.

In optimization process, xanthan gum is added alone to formulation abc obtaining formulation X, in addition, xanthan gum in combination with cetyl alcohol is used to obtain formulation F,then release studies were evaluated.
According to data obtained from release profiles, prepared tablets with both hydrophilic and hydrophobic retard agent (HPMC K4M 30%, xanthan gum 2%, cetyl alcohol 2%) have revealed similar profile of release the active agent according to USP limited range. Furthermore, the release studies have shown that swelling, swelling/erosion and dissolution were the most important mechanisms that could affect the release profile. It also suggested that the percentage release of formulation F was followed Higuchi model.
Keywords
Keyword: Levetiracetam; Hydroxyl Propyl Methyl cellulose; Drug release; Factorial Design
Main Subjects
Pharmaceutical ethics
Statistics
Article View: 285
PDF Download: 133